Original Query: ALL
Previous Study | Return to List | Next Study

Asthma Patient Survey Study to Assess Asthma Effect and Medication in Finland

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00681382
Recruitment Status : Completed
First Posted : May 21, 2008
Last Update Posted : January 24, 2011
Information provided by:

Brief Summary:
This study was aimed at clarifying how the asthma medication is used in practice and how asthma affects everyday life. Total of 106 GPs were asked to recruit patients using inhaled steroid as maintenance treatment for asthma to take part in a telephone survey. Altogether 142 patients were interviewed.

Condition or disease

Study Type : Observational
Actual Enrollment : 142 participants
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: INSPIRE Asthma Patient Survey to Clarify the Use of Asthma Medication and Effects of Asthma in Everyday Life in Finland
Study Start Date : October 2006
Primary Completion Date : April 2007
Study Completion Date : April 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Asthma
U.S. FDA Resources

Asthma patients using inhaled steroids as maintenance treatment

Primary Outcome Measures :
  1. Patients perceptions about treatment of asthma, asthma medication and what are the most common triggers that cause exacerbations. [ Time Frame: Single occasion ]

Secondary Outcome Measures :
  1. How patients react to the first signs of worsening of asthma i.e. how they use asthma medication during stable phase and asthma exacerbation [ Time Frame: Single occasion ]
  2. How asthma affects everyday life [ Time Frame: Single occasion ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Primary care clinic

Inclusion Criteria:

  • Diagnosed persistent asthma
  • regular use of inhaled steroids and concomitant medication

Exclusion Criteria:

  • never been diagnosed COPD
  • seasonal asthma

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00681382

Sponsors and Collaborators
Study Director: Airi Puhakka AstraZeneca Finland
Principal Investigator: Jouni Hedman South Karelia Central Hospital, Finland

Responsible Party: Klaus Tamminen - MC Medical Director, AstraZeneca Identifier: NCT00681382     History of Changes
Other Study ID Numbers: NIS-RFI-SYM-2006/1
First Posted: May 21, 2008    Key Record Dates
Last Update Posted: January 24, 2011
Last Verified: January 2011

Keywords provided by AstraZeneca:
use of asthma medication
asthma control
telephone survey
patient's perception

Additional relevant MeSH terms:
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases